Inside Big Pharma with @hedleyrees - @JohnnyVedmore Live https://t.co/oNwWb7QS3F
— Johnny Vedmore (@JohnnyVedmore) February 6, 2025
Compliance Online explains that,
Hedley Rees is the author of "Supply Chain Management in the Drug Industry" and is a practicing consultant, coach and trainer, operating through his company Biotech PharmaFlow. He helps companies build, manage and improve their clinical trial and commercial supply chains.
Prior to his time at Biotech Pharmaflow, Hedley held senior supply chain management positions at Bayer, British Biotech, Vernalis, Johnson & Johnson and OSI Pharmaceuticals. He holds an Executive MBA from Cranfield University School of Management and is a corporate member of the UK's Chartered Institute of Purchasing and Supply (MCIPS). He is also a member of the UK BioIndustry Association's Manufacturing Advisory Committee, regularly speaks at international conferences and is co-chair of this year's FDA/Xavier University sponsored Global Outsourcing Conference in Cincinnati. His specific interest is in helping drive industry improvements through the regulatory modernization frameworks of FDA and ICH Q8 - Q10. He believes that along with the regulatory guidelines, it is imperative that companies developing and selling drugs make a massive cultural and mindset shift to enable improvements to stick.
03:00. Johnny Vedmore from Wales will be talking about Big Pharma today with Hedley Rees whom he has spoken to a fair few times before and who is a fellow Welshman.
05:27. REES. Learned his skills outside of Pharma in electronics, automotive, and steel basic operations. He's a production engineer and joined a company in Bridgend, Wales in 1979 at Miles Laboratories, which was manufacturing Alka-Seltzer for Europe. We also made sterile injectables which are exactly what these injections are, these vaccines, and we made topical ointments in cream. We really were in the day when the factory made everything from start to finish. We'd buy the raw materials and then you convert them into the finished product and then you'd actually ship them to the pharmacies and clinics and even GP surgeries, so it's fully integrated. I'd spent 16 years there. I left in 1996 to join the biotech industry, British Biotech, and British biotech nearly brought the biotech industry to its knees because when I joined the share price was 27lb. They were bigger than rail track and W.H. Smith, and when I left the share price was about 12 piece
